NAUT
Nautilus Biotechnology, Inc.
Key Financials
Operating Income
$-576035
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D/A | 8/14/2026 | View on SEC |
| 10-Q | 7/28/2026 | View on SEC |
| 8-K | 7/28/2026 | View on SEC |
| SCHEDULE 13D/A | 6/30/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 8-K | 6/18/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NAUT |
| Company Name | Nautilus Biotechnology, Inc. |
| CIK | 1808805 |
| Sector | Laboratory Analytical Instruments |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3826 |
| SIC Description | Laboratory Analytical Instruments |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 206-333-2001 |